scholarly journals Monitoring recovery from traumatic brain injury using the automated neuropsychological assessment metrics (ANAM V1.0)

1996 ◽  
Vol 11 (5) ◽  
pp. 419-420 ◽  
Author(s):  
D.M. Levinson ◽  
D.L. Reeves
2019 ◽  
Vol 34 (6) ◽  
pp. 932-932
Author(s):  
C Grills ◽  
P Armistead-Jehle ◽  
D Cooper

Abstract Objective The Automated Neuropsychological Assessment Metrics (ANAM) is the currently mandated Neurocognitive Assessment Tool (NCAT) for the Department of Defense for pre-deployment baseline testing and is the recommended tool for post-concussion evaluation and return to duty decision making. An ANAM performance validity measure has undergone initial validation (Roebuck-Spencer, Vincent, Gilliland, Johnson and Cooper, 2013). However, cross validation in other samples is warranted, particularly in order to establish cut-points for utilization in the evaluation of mTBI/concussion. The current study retrospectively examined the operating characteristics of the ANAM PVI relative to a more established performance validity test (PVT) in a sample of active duty Service Members referred for neurocognitive screening postconcussion in an Army brain injury clinic. Method Retrospective review of 172 US Service Members referred for neurocognitive screen for possible mild traumatic brain injury/concussion on average 3.8 years post injury (range = 8 days to 27 years) and administered the ANAM, Word Memory Test (WMT), and Neuropsychological Assessment Battery Screening Module (NAB-S). Results Utilizing the WMT as the criterion measure, ROC analysis was significant with AUC = 0.894 (p < 0.001). At 90.09% specificity (95% CI = 83.0% - 94.9%), the optimal cut-point was ANAM PVM ≥ 6, and resulted in 67.21% sensitivity (95% CI = 54.0% - 78.7%). Conclusions The standard ANAM PVI clinical report utilizes a cut-point of 14; however, the current data indicate a cut-point of ≥ 6 may be better suited for patients with mTBI/concussion.


2020 ◽  
Vol 35 (6) ◽  
pp. 1042-1042
Author(s):  
Ivins B ◽  
Arrieux J ◽  
Cole W ◽  
Iverson G

Abstract Objective Several cognition composite scores have been developed for potential use in traumatic brain injury clinical trials. This analysis examined the equivalence of overall test battery mean (OTBM) from two different test batteries administered consecutively to the same subjects. Methods Soldiers were administered the Automated Neuropsychological Assessment Metrics (version 4) TBI-MIL (ANAM4) computerized battery and D-KEFS as part of a larger study comparing within-subject performance from different neuropsychological test batteries. Data from 121 soldiers with complete and valid data on both ANAM4 and D-KEFS and no recent TBI were used in this analysis. OTBMs were calculated for ANAM4 and the seven D-KEFS achievement scores. The OTBMs from the 121 soldiers were ranked from lowest to highest and the percentile rankings from each battery were compared. For each soldier, the differences between the percentile ranks from each battery were also calculated. Results Only 53.8% of soldiers who scored below the 20th percentile on ANAM4 also scored below the 20th percentile on D-KEFS. Furthermore, only 47.8% of soldiers who scored at or above the 80th percentile on ANAM4 also scored in that range on D-KEFS. Some soldiers’ performance on each battery diverged by large amounts, for example from 59.5 to 82.6 percentage points. Correlation analysis revealed that the OTBMs and percentile rankings from both batteries were modestly correlated (OTBM r = 0.515, p &lt; 0.001, percentile rank r = 0.499, p &lt; 0.001). Conclusion These results suggest that comparing similar cognition composites from different neuropsychological test batteries from different studies in a meta-analytic manner may not be feasible due to psychometric difference between batteries.


2020 ◽  
pp. 131-137
Author(s):  
Kimberly R. Bradley ◽  
◽  
Jamie L. Krassow ◽  
Michael F. Richards ◽  
Devin P. Beckstrand ◽  
...  

Introduction: Altitude chamber exposures are used for training to allow aircrew to experience their hypoxia and pressure effect symptoms. Decompression illness (DCI) can occur subsequent to altitude chamber training or in operational aircraft when the cabin altitude is at least 18,000 feet. Definitive emergent treatment is hyperbaric oxygen (HBO2) to decrease bubble size, dissipate excess nitrogen hyperoxygenate tissue and reduce inflammation. Case report: A 27-year-old female underwent altitude chamber training to 25,000 feet. She developed tingling in both legs and left arm, headache, dizziness, malaise, then difficulty talking. She underwent two HBO2 treatments. Over the next 12 months she had paresthesia, decreased memory and cognitive function similar to symptoms seen following traumatic brain injury. She was referred 14 months after the event for evaluation. Using pre-deployment Automated Neuropsychological Assessment Metrics (ANAM) and serial tests over 58 HBO2 treatments, the patient demonstrated near-return to her pre-deployment test scores. Discussion: The reason for HBO2 treatment was based on previous experience with chronic traumatic brain injury subjects where HBO2 improved outcome. The patient’s chronic neurological symptoms mimicked chronic TBI. The patient was unique in that baseline cognitive tests existed that could be used to monitor her changes during the treatment series.


Sign in / Sign up

Export Citation Format

Share Document